Over the past decade the number of recommended and funded vaccines for adolescents has increased, becoming a substantial part of the National Immunisation Program in Australia. In response, NSW has implemented disease-specific vaccination campaigns for both children and adolescents and more recently established a routine high school-based vaccination program to administer vaccines to this often hard to reach group. This paper outlines the history of school-based vaccination in NSW from its commencement in 1971 to coverage from early disease-specific programs, and describes the implementation of the current program of routine vaccination. Substantial coverage has been achieved across the age spectrum 5-17 years, highlighting the effectiveness of the school-based vaccination program in reaching large numbers of adolescents.
History
The earliest recorded national school-based vaccination services in Australia provided the diphtheria toxoid vaccine from 1932-1936. This was followed by the introduction of the Bacillus of Calmette and Guérin vaccine (BCG for tuberculosis) which was provided through school-based vaccination programs in some jurisdictions from the late 1940s to the mid-1980s. Polio vaccine was also provided in some schools during the 1950s and 1960s as part of larger mass vaccination programs. 1, 8 More recently, school-based vaccination services commenced in NSW in 1971 when the monovalent rubella vaccine was administered to girls in the first year of high school (Table 1) . 8, 9 The schoolgirl rubella program was implemented in rural areas by community health staff, while in metropolitan areas an independent team of two school immunisation nurses provided this service. This model continued into the late 1990s, providing the platform for the change to measles-mumps-rubella (MMR) vaccine from 1994 and the vaccination of boys from 1996. 8, 9 The National Measles Control Campaign in 1998 brought the second dose of MMR vaccine forward to 4-5 years of age, necessitating a one-off catch-up campaign for the whole of primary school (5-12 years of age). 10, 11 The school-based program for MMR vaccine was then disbanded due to lack of resources.
The National Health and Medical Research Council recommended National Hepatitis B Vaccine Program for children aged 10-13 years was implemented through general practice in NSW from 1999 until it was incorporated into the Adolescent Vaccination Program in 2004. 12 An evaluation undertaken in 2001 found high levels of awareness and support among parents but low coverage (18%) through private sector service provision. 12, 13 The National Meningococcal C Vaccination Program targeted all children and young people aged 12 months to 19 years and commenced in January 2003. 14, 15 In NSW, this was implemented through a whole of high school vaccination program in 2003 and a whole of primary school program in 2004. This was the catalyst for the reestablishment of routine school-based vaccination in NSW through the Adolescent Vaccination Program.
Due to increased pertussis notifications in high schoolaged children a whole of high school vaccination program with diphtheria-tetanus-pertussis (dTpa) vaccine was conducted across NSW in 2004, 16 Table 1) .
Current NSW Adolescent Vaccination Program
The Australian Government provides funding to each state and territory for the purchase of vaccines on the National Immunisation Program, including all vaccines administered through the NSW Adolescent Vaccination Program. It also provides a contribution to service provision. The NSW Government provides funding for training and service delivery to enable the implementation of the Adolescent Vaccination Program in all public and private high schools. Overall coordination is provided by the NSW Department of Health Immunisation Unit, while delivery is conducted through the area health services (AHSs). 18 A minority of high schools refuse to participate due to a philosophical objection to vaccination. These schools are provided with information about the program to distribute to parents; those parents who would like for their child to be vaccinated are advised to visit their general practitioner. 19 Each high school holds 3-4 vaccination clinics during each school year. Scheduling of vaccines is based around the 3-dose HPV course with other vaccines organised to minimise the number of injections per visit and to meet required dose intervals. Clinic dates are organised by AHSs in the year prior to implementation. Each school is contacted 2-3 days prior to a clinic to ascertain the approximate numbers of students requiring vaccination and to discuss logistical arrangements.
All registered nurses who administer vaccines in the NSW Adolescent Vaccination Program are authorised nurse immunisers. They have completed specialist training and attend annual cardiopulmonary resuscitation training and seminars to ensure they are up to date with best practice immunisation policy. 20 Since 2007 in most AHSs, school immunisation nurses have been supported by St John Ambulance (NSW) Immunisation Program volunteers who assist students both prior to and after vaccination.
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Each school clinic is staffed by a minimum of two authorised nurse immunisers, a team leader/coordinator and rostered St John Ambulance (NSW) volunteers if they are available. In addition, a number of school staff members are required to distribute consent forms and supervise the students. 23 Vaccinated students must remain in the vicinity of the place of vaccination and under adult supervision for at least 15 minutes following vaccination. School-based immunisation nurses are required to remain at the school for 15 minutes after the last student has been vaccinated. Students who miss a dose through illness or absenteeism are offered catch-up vaccination through AHSs or general practice.
Consent
NSW education authorities have advised that all students, including those aged 18 years and over, require written vaccine-specific consent signed by their parent/guardian. Students can refuse vaccination even if prior written consent has been provided by their parent/guardian.
Resources
Program resources, including parent information kits, templates of letters and newsletter articles, are developed by the NSW Department of Health for use by AHSs. These resources are designed to assist AHSs in communicating with schools about the Adolescent Vaccination Program. A Parent Information Kit for each type of vaccine is provided in a colour-coded envelope and contains: questions and answers about the vaccine/disease; a consent form with a record of vaccination; a privacy leaflet; and contacts for all NSW public health units. A Student Advice Card is distributed immediately prior to vaccination, outlining what students should expect in the vaccination encounter. Additionally, the Adolescent Vaccination Program section of the NSW Health website has general information for both parents and students. 19 Some AHSs may develop additional communication and/or promotional materials for use in their area. Adverse events following immunisation are closely monitored by immunisation teams at schools and notified immediately to the public health unit. AHSs are required to report all serious adverse events to the NSW Department of Health. 18 An overview of the national assessment and reporting processes for adverse events following immunisation notified by public health units is published in the accompanying paper in this issue 24 as well as in other national publications. 25 Vaccine wastage is recorded for each school clinic. Data are aggregated at an AHS level and provided quarterly to the NSW Department of Health Immunisation Unit.
Coverage
The earliest available data describing vaccine coverage for NSW adolescents is from the National Hepatitis B Vaccine Program (1999) (2000) . Coverage from this general practice program was measured through a telephone survey of the parents/carers of NSW children aged 10-13 years and was estimated as 18%. 12 Coverage achieved by the National Measles Control Campaign was measured through standardised data collected at the time of vaccination. Coverage for NSW primary school-aged children was estimated as 75.4%. More detailed results of this campaign are reported elsewhere.
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Coverage for early disease-specific and time-limited school-based vaccination programs in NSW (meningococcal C and dTpa) are presented in Table 2 (44%, 72 076) than primary (76%, 401 363) and secondary schools (76%, 349 758) (p o 0.001) as many children aged 4-5 years were vaccinated by general practitioners. In primary schools there was a statistically significant trend of coverage increasing with increasing school year (p o 0.001), while in high school this trend was reversed (p o 0.001). When examined by AHS, combined coverage of both primary and high schools was significantly higher in the rural AHSs (80%) compared with metropolitan AHSs (73%) (p o 0.001), ranging from 69% to 85% (Table 2) .
During the 2004 dTpa vaccination program, 274 364 (56%) eligible children were vaccinated. Coverage varied by AHS, ranging from 48% to 63%. As there were no program delivery issues unique to any AHS, the variation in coverage is likely to have occurred due to differences in the demographics of the population in that area, such as conscientious objection, which affect coverage in other age groups. 26 Coverage may also have been affected by the National Health and Medical Research Council recommendation that children who had received dT vaccine in the previous 5 years were not eligible to receive dTpa vaccine through this program. Coverage was similar in metropolitan and regional schools (56% and 55% respectively) and only slightly lower in remote schools (49%), although this difference was statistically significant (p o 0.001). There was a statistically significant association between school type and immunisation coverage (p o 0.001), with higher coverage seen in Catholic schools (60%) compared with government (55%) and independent schools (50%). This association was not confounded by school location or the socioeconomic status of the local area. Immunisation coverage was similar in schools of varying size. Coverage decreased with higher school years, particularly in Years 11 and 12, with a statistically significant inverse trend in coverage and school year (p o 0.001).
The re-introduction of dTpa into the Adolescent Vaccination Program from 2009 resulted in 68% coverage of eligible Year 10 students with coverage higher than the 2004 program across all AHSs (range 61-71%). Other vaccines delivered through the Adolescent Vaccination Program in 2009 targeted Year 7 students, with statewide coverage ranging from 34% for varicella vaccine (in students with no previous clinical disease) to 80% for HPV (dose 1). Coverage is consistently higher for the first dose of both hepatitis B (63% versus 50%) and HPV (80% versus 77% versus 69%) vaccines which require multiple doses. 27 Further detail on coverage for the 2009 Adolescent Vaccination Program is presented in the accompanying paper in this issue. 27 
Discussion
There are many challenges in vaccinating adolescents in comparison to younger age groups, including their increased mobility, limited visits to general practice and the need to obtain consent from parents who are not present at the vaccination. 28, 29 Despite these challenges, schoolbased vaccination in NSW has achieved high coverage, which is similar to or better than that achieved in other Australian jurisdictions [30] [31] [32] [33] and higher than in settings where adolescent vaccines are implemented through primary care.
34, 35 The higher coverage consistently achieved in the early high school years has resulted in a transition towards delivering the majority of routine vaccines in Year 7. The implementation of the statewide adolescent vaccination register will be another substantial improvement to the program as it will improve access to individual vaccination records and enhance accuracy of coverage data used to monitor program effectiveness.
Conclusion
The NSW Adolescent Vaccination Program has evolved considerably over the last decade in response to available evidence and increased availability of and recommendations for adolescent vaccines. Integral to its success is the collaborative and coordinated approach to service delivery, the cooperation of the NSW education authorities and school principals, and the highly skilled workforce involved in its implementation.
